FDA Adverse Event Malfunction Summary report: N

REAGENT RED BLOOD CELLS BIOTESTCELL I11

MDR report key: 2500828 · Received March 23, 2012

Report

Report Number
9610824-2012-00033
Event Type
Malfunction
Date Received
March 23, 2012
Date of Event
February 29, 2012
Report Date
March 23, 2012
Manufacturer
BIO-RAD MEDICAL DIAGNOSTICS GMBH
Product Code
KSZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS IS OUR COMBINED INITIAL AND FINAL REPORT ON THIS INCIDENT.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT CELL #10 OF BIOTESTCELL-I11 SEEMED TO BE LE(B) NEGATIVE ALTHOUGH THE ANTIGEN PROFILE SHEET LISTS IT AS LE(A-B+). WE DID NOT RECEIVE THE SUPPOSEDLY DEFECTIVE PRODUCT. THEREFORE OUR QUALITY CONTROL LABORATORY HAD TESTED THE RETAINED SAMPLE OF BIOTESTCELL-I11 AND THIS TESTING CONFIRMED THE CUSTOMER´S RESULT. FURTHER TESTINGS CONFIRMED THAT THE AFFECTED CELL #10 IS LE(A-B-). BECAUSE OF THE MISTYPING OF CELL#10 A RISK ANALYSIS WAS PERFORMED. THE RESULT OF THIS RISK ANALYSIS WAS THAT THERE IS NO RISK FOR USERS OF BIOTESTCELL-I11: BIOTESTCELL-I11 IS USED FOR THE IDENTIFICATION OF UNEXPECTED ANTIBODIES. THE ANTIBODY LE(B) HAS NO CLINICAL SIGNIFICANCE. ANTI-LE(B) DOES NOT CAUSE A TRANSFUSION REACTION. IN ADDITION TO THE AFFECTED CELL #10 THERE ARE MORE LE(B) POSITIVE CELLS DOCUMENTED IN THE ANTIGEN PROFILE SHEET OF BIOTESTCELL-I11. THEREFORE AN IDENTIFICATION OF AN ANTI-LE(B) IS POSSIBLE DESPITE THE FAILURE IN THE ANTIGEN PROFILE SHEET. DUE TO THE CONFIRMED COMPLAINT FURTHER ACTIONS WERE INITIATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 REAGENT RED BLOOD CELLS BIOTESTCELL I11 BIOTESTCELL I-11 KSZ BIO-RAD MEDICAL DIAGNOSTICS GMBH 8205011

Patients

Seq Age Sex Outcome Treatment
1 IMMUCOR ANTI-LEB